| NCT ID | NCT07783152 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Lupus Nephritis (LN) |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2026-10-14 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2026-10-14 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 patients. Activities include answering surveys and participating in an interview. Objectives include: 1) Assess feasibility and acceptability of the LN Care Pathway, 2) evaluate user experiences to identify opportunities for improvement, and 3) explore the preliminary effect of this pathway on medication adherence and clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Active patient at a Duke University Health System clinic * Current diagnosis of Systemic Lupus Erythematosus (SLE) based on the 1997 ACR,32 2012 Systemic Lupus International Collaborating Clinics (SLICC),33 or 2019 European League Against Rheumatism (EULAR)/ACR (American College of Rheumatology)34 classification criteria * Aged 18 years or older * Able to provide informed consent * Able to attend telemedicine visits * New onset or ongoing active LN based on rheumatologist or nephrologist evaluation Exclusion Criteria: * Patients with severe cognitive impairment * Do not wish to receive longitudinal care at our health system
Contact & Investigator
Kai Sun, MD, MS
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT07783152 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lupus Nephritis (LN). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07783152 currently recruiting?
Yes, NCT07783152 is actively recruiting participants. Contact the research team at edna.scarlett@duke.edu for enrollment information.
Where is the NCT07783152 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT07783152 clinical trial?
NCT07783152 is sponsored by Duke University. The principal investigator is Kai Sun, MD, MS at Duke University. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.